Ying-Li Lin

704 citations
36 papers · 497 indexed · h-index 15
Topics
Epigenetics and DNA Methylation (14 papers)Bladder and Urothelial Cancer Treatments (11 papers)Urinary and Genital Oncology Studies (9 papers)
Partner nations
ChinaTaiwan

In The Last Decade

Ying-Li Lin

35 papers receiving 490 citations

Peers

Ying-Li Lin
Comparison fields: 5 of 79
  • Molecular Biology 242
  • Surgery 134
  • Pulmonary and Respiratory Medicine 124
  • Cancer Research 103
  • Oncology 101
Replace Nilüfer Avcı with:
Nilüfer Avcı Türkiye
Takafumi Hashimoto Japan
Christine Bekos Austria
Mark Rochester United Kingdom
Kairui Jin China
Michelle B. Nadler Canada
Esin Oktay Türkiye
Chih‐Long Chang Taiwan
Cindy Lim Singapore
Ying-Li Lin relative to Nilüfer Avcı Türkiye Nilüfer Avcı's profile →
Citations per field
00.5×3.8×
Nilüfer Avcı · 1×
Citations per year

Countries citing papers authored by Ying-Li Lin

Since Specialization
Citations

This map shows the geographic impact of Ying-Li Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying-Li Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying-Li Lin more than expected).

Fields of papers citing papers by Ying-Li Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ying-Li Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying-Li Lin. The network helps show where Ying-Li Lin may publish in the future.

Co-authorship network of co-authors of Ying-Li Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Ying-Li Lin. A scholar is included among the top collaborators of Ying-Li Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ying-Li Lin. Ying-Li Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 1
4 6
5 3
6 2
7 1
8 4
9 31
10 24
11 48
12
Reduktion der Blasenaktivität auf FDG-PET/CT-Aufnahmen bei Patienten mit Blasenkarzinom
2
13 18
14 22
15 44
16 5
17 1
18 9
19 13
20 13

About Ying-Li Lin

Ying-Li Lin is a scholar working on Cancer Research, Surgery and Molecular Biology, having authored 36 papers that have together received 497 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (14 papers), Bladder and Urothelial Cancer Treatments (11 papers) and Urinary and Genital Oncology Studies (9 papers). The work is most often cited by research in Cancer Research (103 citations), Pulmonary and Respiratory Medicine (124 citations) and Oncology (101 citations). Ying-Li Lin has collaborated with scholars based in China and Taiwan. Frequent co-authors include Jianguo Ma, Wenping Li, I‐Ching Lin, Yuwen Yang, Zhigang Li, Zhian Li, Jianming Zhu, Mei‐Feng Wu, Yanling Wang and Yen‐Tze Liu. Their work appears in journals such as Scientific Reports, International Journal of Environmental Research and Public Health and Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026